These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 6801075

  • 1. "Medical oophorectomy" using a long-acting GNRH agonist--a possible new approach to the treatment of endometriosis.
    Meldrum DR, Chang RJ, Lu J, Vale W, Rivier J, Judd HL.
    J Clin Endocrinol Metab; 1982 May; 54(5):1081-3. PubMed ID: 6801075
    [Abstract] [Full Text] [Related]

  • 2. Dynamics of plasma gonadotropin and sex steroid release in polycystic ovarian disease after pituitary-ovarian inhibition with an analog of gonadotropin-releasing hormone.
    Calogero AE, Macchi M, Montanini V, Mongioi A, Maugeri G, Vicari E, Coniglione F, Sipione C, D'Agata R.
    J Clin Endocrinol Metab; 1987 May; 64(5):980-5. PubMed ID: 3104389
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
    Filicori M, Campaniello E, Michelacci L, Pareschi A, Ferrari P, Bolelli G, Flamigni C.
    J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
    [Abstract] [Full Text] [Related]

  • 8. Induction of hot flashes in premenopausal women treated with a long-acting GnRH agonist.
    DeFazio J, Meldrum DR, Laufer L, Vale W, Rivier J, Lu JK, Judd HL.
    J Clin Endocrinol Metab; 1983 Mar; 56(3):445-8. PubMed ID: 6401756
    [Abstract] [Full Text] [Related]

  • 9. Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in the human male. III. Effects of long term combined treatment with GnRH agonist and androgen.
    Bhasin S, Heber D, Steiner BS, Handelsman DJ, Swerdloff RS.
    J Clin Endocrinol Metab; 1985 May; 60(5):998-1003. PubMed ID: 3920237
    [Abstract] [Full Text] [Related]

  • 10. Therapeutic use of pituitary desensitization with a long-acting lhrh agonist: a potential new treatment for idiopathic precocious puberty.
    Crowley WF, Comite F, Vale W, Rivier J, Loriaux DL, Cutler GB.
    J Clin Endocrinol Metab; 1981 Feb; 52(2):370-2. PubMed ID: 6780592
    [Abstract] [Full Text] [Related]

  • 11. Gonadotropin-releasing hormone agonist suppresses ovulation, menses, and endometriosis in monkeys: an individualized, intermittent regimen.
    Werlin LB, Hodgen GD.
    J Clin Endocrinol Metab; 1983 Apr; 56(4):844-8. PubMed ID: 6403565
    [Abstract] [Full Text] [Related]

  • 12. Effects of the (imBzl)D-His6, Des-Gly analog of GnRH on gonadotropin and estradiol secretion in normal women.
    DeFazio J, Lu JK, Vale W, Rivier J, Judd HL, Meldrum DR.
    Endocr Res; 1984 Apr; 10(2):163-70. PubMed ID: 6437804
    [Abstract] [Full Text] [Related]

  • 13. Clinical and hormonal effects of chronic gonadotropin-releasing hormone agonist treatment in polycystic ovarian disease.
    Steingold K, De Ziegler D, Cedars M, Meldrum DR, Lu JK, Judd HL, Chang RJ.
    J Clin Endocrinol Metab; 1987 Oct; 65(4):773-8. PubMed ID: 3116031
    [Abstract] [Full Text] [Related]

  • 14. Long term treatment of male and female precocious puberty by periodic administration of a long-acting preparation of D-Trp6-luteinizing hormone-releasing hormone microcapsules.
    Roger M, Chaussain JL, Berlier P, Bost M, Canlorbe P, Colle M, Francois R, Garandeau P, Lahlou N, Morel Y.
    J Clin Endocrinol Metab; 1986 Apr; 62(4):670-7. PubMed ID: 2936759
    [Abstract] [Full Text] [Related]

  • 15. Long-term administration of gonadotropin-releasing hormone agonist and dexamethasone: assessment of the adrenal role in ovarian dysfunction.
    Cedars MI, Steingold KA, de Ziegler D, Lapolt PS, Chang RJ, Judd HL.
    Fertil Steril; 1992 Mar; 57(3):495-500. PubMed ID: 1531463
    [Abstract] [Full Text] [Related]

  • 16. Gonadotropin and steroid secretory patterns during chronic treatment with a luteinizing hormone-releasing hormone agonist analog in men.
    Evans RM, Doelle GC, Alexander AN, Uderman HD, Rabin D.
    J Clin Endocrinol Metab; 1984 May; 58(5):862-7. PubMed ID: 6423661
    [Abstract] [Full Text] [Related]

  • 17. Expression of gonadotropin-releasing hormone (GnRH) receptor gene is altered by GnRH agonist desensitization in a manner similar to that of gonadotropin beta-subunit genes in normal and castrated rat pituitary.
    Lerrant Y, Kottler ML, Bergametti F, Moumni M, Blumberg-Tick J, Counis R.
    Endocrinology; 1995 Jul; 136(7):2803-8. PubMed ID: 7789305
    [Abstract] [Full Text] [Related]

  • 18. The relationship between luteinizing hormone and estradiol secretion in female precocious puberty: evaluation by sensitive gonadotropin assays and the leuprolide stimulation test.
    Garibaldi LR, Aceto T, Weber C, Pang S.
    J Clin Endocrinol Metab; 1993 Apr; 76(4):851-6. PubMed ID: 8473395
    [Abstract] [Full Text] [Related]

  • 19. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.
    Rebar R, Judd HL, Yen SS, Rakoff J, Vandenberg G, Naftolin F.
    J Clin Invest; 1976 May; 57(5):1320-9. PubMed ID: 770505
    [Abstract] [Full Text] [Related]

  • 20. Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist plus medroxyprogesterone acetate.
    Cedars MI, Lu JK, Meldrum DR, Judd HL.
    Obstet Gynecol; 1990 Apr; 75(4):641-5. PubMed ID: 2138265
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.